Arrow Financial’s Labcorp LH Stock Holding History

Arrow Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-110	Closed	-$24.6K	–	251
2024 Q3	$24.6K	Hold	110	–	–	﹤0.01%	253
2024 Q2	$22.4K	Hold	110	–	–	﹤0.01%	251
2024 Q1	$24K	Hold	110	–	–	﹤0.01%	245
2023 Q4	$25K	Hold	110	–	–	﹤0.01%	244
2023 Q3	$22.1K	Sell	110 -18	-14%	-$3.8K	﹤0.01%	257
2023 Q2	$26.5K	Hold	128	–	–	﹤0.01%	237
2023 Q1	$25.2K	Hold	128	–	–	﹤0.01%	242
2022 Q4	$26K	Buy	128 +12	+10%	+$2.35K	﹤0.01%	246
2022 Q3	$20K	Hold	116	–	–	﹤0.01%	257
2022 Q2	$23K	Hold	116	–	–	﹤0.01%	249
2022 Q1	$26K	Hold	116	–	–	﹤0.01%	251
2021 Q4	$31K	Buy	116 +58	+100%	+$14.4K	﹤0.01%	236
2021 Q3	$14K	Hold	58	–	–	﹤0.01%	275
2021 Q2	$14K	Hold	58	–	–	﹤0.01%	278
2021 Q1	$13K	Hold	58	–	–	﹤0.01%	277
2020 Q4	$10K	Buy	+58	New	+$10K	﹤0.01%	273
2016 Q1	–	Sell	-61	Closed	-$6K	–	426
2015 Q4	$6K	Buy	+61	New	+$6.29K	﹤0.01%	324
2015 Q2	–	Sell	-49	Closed	-$5K	–	372
2015 Q1	$5K	Buy	+49	New	+$5.04K	﹤0.01%	330

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Arrow Financial's LH Position: Q4 2024 in Review

Arrow Financial sold out of Labcorp (LH) in Q4 2024, closing a stake of 110 shares — an estimated $24.6K sold.

Arrow Financial first reported a position in LH in Q1 2015 and held it in 18 quarters. The position peaked at $31K in Q4 2021. 926 funds tracked by Wall St. Rank hold LH as of Q4 2024.

Arrow Financial reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
Arrow Financial sold 110 Labcorp shares in Q4 2024, an estimated $24.6K.
Arrow Financial first reported a position in Labcorp in Q1 2015 and held it in 18 quarters.
Arrow Financial's Labcorp position peaked at $31K in Q4 2021.
926 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.